NMI Holdings, Inc. <NMIH.O>: BTIG assumes coverage with buy rating; price target $54
NMIH•Related News
Lexeo Therapeutics Enters Into Agreement To Acquire Mantle Therapeutics And Announces Multiple New Strategic Collaborations To Expand Leadership In Friedreich Ataxia
LXEO•
Mgic Investment Corporation <MTG.N>: BTIG Assumes Coverage With Neutral Rating
MTG•
Jefferies initiates Crane NXT at 'buy' on margin expansion potential
CXT•
Cognex Corporation - To Grant Rsus Valued At $45 Million-$55 Million To Realsense Employees
CGNX•
Viking Therapeutics Announces Positive Topline Results From Maintenance Study Of Glp-1/Gip Agonist Vk2735 Demonstrating The Promise Of Multiple Maintenance Dosing Regimens
VKTX•